Skip to main content
. 2018 Oct 10;9:2417. doi: 10.3389/fmicb.2018.02417

FIGURE 1.

FIGURE 1

Final assay plate layout. Column 1 contains positive control (Niclosamide) in Rows A–D and negative control (DMSO) in Rows E–H. Column 12 contains bacteria-free control wells. Compounds are tested in Rows A–G as 10-pt serial twofold dilutions. Row H contains a control twofold dilution of niclosamide starting at 25 μM in Column 2.